Led by Constadina Panagiotopoulos, MD, the TrialNet team at University of British Columbia is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, University of British Columbia is regionally overseen by The Hospital for Sick Children. If you reach out to TrialNet, you may be contacted by staff from either institution.